Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study

Fig. 3

Tau SUVr progression in AD patients according to individual baseline tau tracer uptake. A Representation of the individual trajectories of the tau-PET SUVr in the temporoparietal meta-VOI in AD patients according to baseline SUVr values. B Results of the voxelwise correlation between baseline tau SUVr values (Tau1) and their progression over time (Tau2-Tau1) in AD patients with age, sex, ApoE genotype, and CDR-SOB as covariates. C Average annualized differences (Tau2-Tau1) in SUVr between the two tau PET exams in low-Tau1 AD patients. D Average annualized differences (Tau2-Tau1) in SUVr between the two tau PET exams in high-Tau1 AD patients (projection on the 3D MRI MNI template). RFT-based multiple comparison correction with a clusterwise threshold of p < 0.001 and a cluster-forming threshold of p < 0.001 in B

Back to article page